3
Announcements
Trials
Browse
Landscape
Phase
Phase 3
1
Status
Terminated
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
CNS
2
Plasma cell
1
Lymphoid
1
Conditions
Lymphoma
74
Lymphoma, Large B-Cell, Diffuse
55
Lymphoma, Non-Hodgkin
54
Lymphoma, Mantle-Cell
40
Lymphoma, Follicular
37
Hodgkin Disease
36
Lymphoma, Large-Cell, Immunoblastic
26
Burkitt Lymphoma
25
Leukemia, Lymphocytic, Chronic, B-Cell
22
Precursor Cell Lymphoblastic Leukemia-Lymphoma
20
Lymphoma, B-Cell, Marginal Zone
15
Leukemia
10
Recurrence
9
Lymphoma, B-Cell
9
Lymphoma, T-Cell
8
Multiple Myeloma
7
Waldenstrom Macroglobulinemia
6
Neoplasms, Plasma Cell
6
Lymphoma, T-Cell, Cutaneous
6
Lymphoma, T-Cell, Peripheral
5
Lymphoma, Large-Cell, Anaplastic
5
Leukemia, Myeloid, Acute
5
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma
4
Dendritic Cell Sarcoma, Interdigitating
4
Congenital Abnormalities
4
Myelodysplastic Syndromes
3
Leukemia, Myeloid, Chronic-Phase
3
Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative
3
Leukemia, Myeloid, Accelerated Phase
3
Blast Crisis
3
Interventions
Cyclophosphamide
35
Rituximab
33
venetoclax
24
ibrutinib
14
Vincristine
14
Prednisone
14
Doxorubicin
14
Gemcitabine
13
pembrolizumab
12
fludarabine
12
Bendamustine Hydrochloride
11
Etoposide
10
obinutuzumab
9
Filgrastim
9
Dexamethasone
9
Bortezomib
9
fludarabine phosphate
8
Mycophenolic Acid
8
Drug Therapy
8
ofatumumab
7
Whole-Body Irradiation
7
Sirolimus
7
Peripheral Blood Stem Cell Transplantation
7
Methotrexate
7
Busulfan
7
Therapeutics
6
Radiotherapy
6
Mesna
6
Lenalidomide
6
Ipilimumab
6
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Neoplasms
×
Carmustine
×
Lymphoid
×
Clear all
NCT02366663
2018-03-12
SPINOZA
City of Hope Medical Center
Phase 3
Terminated
3 enrolled
8 charts